µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ |s8N
KA3U W
ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ wxN)dB
T j$'B[cv
¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ B2`S0 H
-,bFGTvYQ
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ?h<4trYcv
)G[byBa
1. CD4 j3-YZKpg
+UzQJt/>>
2. T cell receptor(TCR) SV7;B?e%Y
[%W'd9`>
3. immunoglobulin superfamily (IgSF) <-lM9}vd
I-#H+\S
4. selectin UG| /Px ]
5
Qgu:)}
5. anti-idiotypic antibody (¦ÁId) i~B?p[
=8FvkNr
6. major histocompatibility complex(MHC) X>(1fra4
>e]g T
7. immunotolerance
_&KqmQ8$7
2.qPMqH
8. biological reponse modifier(BRM) U,GSWMI/K
Cq5.gk
S<
9. immune reponse gene (Ir gene) ,Eq
QU|
n ]%2Kx
10. reshaped antibody (or reconstituted antibody) 1]xk:u4LA
ew;;e|24
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 7?lz$.*Avp
*,u3Wm|7
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ ,0'GHQWz$
gC7!cn
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? uWS]l[Ga
I| TNo-!$
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ ixTjXl2g
e02Hf{eOfw
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? 6@]o,O
&1\/B
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) _{|a<Keq|
c!w[)>v
¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ ,%!m%+K9a
E|pT6
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? \p^V~fy7rU
s.M39W?
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? qI'pj
TMDY
jUT`V
ZK4&
¡¡ b'4a;k!rS
Mo/R+\u+Y
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ h!tpi`8\z
-TD\?Q
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? k?=1q[RQH
^y,h0?Z9
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? :'h$]p%
D:`Q\za
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ lxd{T3LU
?NBae\6r
ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ mG)5xD
qV=:2m10x
¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Jp jHbG
loA/d
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© A
ojL4H|
Zk`y"[ J
1. CD8 zk<V0NJIL*
S(@kdL
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) ;*?>w|t}w
2G.y.#W
3. immunoglobulin fold(Ig fold) P'wo+Tn*
`E|i8M3g
4. cadherin (Ca-dependent cell adhesion moleculers) n1%2sV)>
f2 ~Aug
5. idiotype-anti-idiotypic antibody immune network theory 8SpG/gl"
pZ8J\4+
6. HLA class II antigen OROvy
1IoW}yT
7. complementarity-determining region (CDR) brp3xgQ`]
np2&W'C/i
8. perforin(or pore-forming protein ,PFP) 3li$)S1z
yKhI&
9. high affinity IL-2 receptor YE@yts
Xz @#,F:@
10. artificial active immunization Dtd~}-_Q
U
2-{p
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 'IY?=#xr'`
=4` wYh
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠwU|@fm"
hDi~{rbmc
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 <O7!(
j4,y+9U
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ |8f }3R 9
tC|?Kl7
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ FD[*Q2fU
P@PF"{S
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) JXL?.{'A
Btxtu"]nJo
1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ ^2}HF/
!`
%j#bv
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? O|sk"YXF
7SS#V
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ =s!0EwDH3
EF!J#N2
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ lIS`_H}
nHm29{G0
¡¡ CPZ,sWg5
K?J_cnJ`
W6T4Zsg
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ QTBc_Z
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ { Z
k^J
@=l6zd@
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ a%.W9=h=M(
D&F{0
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© EA(4xj&:U
w[d8#U
1. immunoglobulin gene rearrangement <&Xl b0
{,JO}
Dmu5
2. the common chain of cytokine receptor (or a cytokine receptor ;Tnid7:S
hhaiHi!$
subunit shared by some cytokine receptors) eMnK@J
.F8[;+
3. flow cytometry(FCM) nrMW5>&-`
Q&.uL}R
4. carrier effect d^A]]Xg
y@l&B+2ks
5. positive selection of T lymphocytes in thymus }},0#Ap
.2c/V
6. mouse TH1(Th1) and TH2(Th2) subsets 5?;<^J
enJ;#a
A
7. perforin (pore-forming protein ,PFP) 6Yn>9llo}=
^'E^*R
8. ADCC(antibody-dependent cell-mediated cytotoxicity) |\Jnr3)
@
&N
9. SH-2(src-homology region 2) ^+D/59I
~BuzI9~7P
10. Ab2¦Â (internal image) j7Fb4;o{
j%s,%#al
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£©
Uo >aQk
I}bu
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? 'r 7[
9[
IOZw[9](+
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? `hO%(9V9
]]K?Q
)9x
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠTHhxj)
5kw
K%
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ )&_bY~P
B-N//ef}
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ0a89<yX
+@?Q "B5u}
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) VQpt1cK*
d]e36Dwk
ÃâÒßѧרҵ£º K
sOSPQDGE
+pqbl*W;1
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ 9f0`HvHC
h@R n)D
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? P_3IFHe
zNX=V!$
´«È¾²¡Ñ§×¨Òµ£º #B~;j5
XA#qBxp/h
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ P
2_!(FZ<l
B0b|+5WhR
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ dY}5Kmt
YaS!YrpI
Ïû»¯×¨Òµ£º 1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ ]\fHc"/
@@\qso
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? h81giY]
L;:PeYPL
+!u9_?Tp
WVyDE1K<
25Z}.))
DtBvfYO8)>
#L!`n)J"
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ jX4$PfOhR
t"Du
ÃâÒßѧÊÔÌâ g0B-<>E
$A~aNI
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© W>!:K^8]
VM5'd
1. Fas(CD95)/FasL 2<UC^vZ
,1 H|{ <
2. common chain of cytokine receptor ih)\P0wed
}~LGq.H
3 . TCR/CD3 complex -,*m\Fe}
H5d@TB,`
4. negaive selection of thymocytes S^~"#
U^[AW$WzU
5. artificial active immune =g6~2p=H
5xKod0bA
6. anti-idiotypic XC<'m{^(m
vO?sHh
7. IgSF N:64Gko"K
"PTEt{qn
8. Integrin j/oc+ M^
q}jh>`d
9. chemokine !ck luj
}Uj-R3]}K
10. B7/CD28 roriNr/e
;xh.95BP`
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© -h|[8UG^b
)RFY2}
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ 1M)88&
1)}hzA
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ RI
'}C`%v
!+Cc^{
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ ,,j> 2Ts
^Hf?["m^@
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ GRj [2I7:
OJydt; a
sjLm-pn3
:zIB3nT^
~_CZ1
&